KMB 📈 Kimberly-Clark - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4943681035
KMB: Diapers, Wipes, Tissues, Towels, Pants, Sanitizers, Protective Equipment
Kimberly-Clark Corporation is a multinational company that designs, manufactures, and markets a wide range of personal care and consumer tissue products. The company's operations are divided into three main segments: Personal Care, Consumer Tissue, and K-C Professional, each catering to distinct consumer needs. The Personal Care segment offers an array of products, including disposable diapers, training pants, baby wipes, and feminine care products, under renowned brand names such as Huggies, Pull-Ups, and Kotex. These products are designed to provide comfort, convenience, and hygiene to consumers, particularly in the areas of infant care, feminine hygiene, and incontinence care.
The Consumer Tissue segment is another critical component of Kimberly-Clark's business, focusing on the production and marketing of facial tissues, bathroom tissues, paper towels, and napkins. Brands like Kleenex, Scott, and Cottonelle are household names, synonymous with quality and reliability. These products are essential for daily household use, providing consumers with the necessary tools for maintaining personal hygiene and cleanliness. The company's ability to innovate and expand its product lines under these brands has been instrumental in maintaining its market share and customer loyalty.
Kimberly-Clark's K-C Professional segment targets the away-from-home market, offering a variety of products designed for use in commercial settings such as offices, healthcare facilities, and manufacturing environments. The segment's product portfolio includes wipers, tissues, towels, and personal protective equipment, all aimed at meeting the hygiene and safety needs of businesses and institutions. Brands like Kleenex, Scott, and Kimtech are prominent in this segment, reflecting the company's commitment to providing high-quality, professional-grade products. This diversification allows Kimberly-Clark to tap into a broader market, leveraging its expertise in tissue products to serve both consumer and commercial demands.
In terms of distribution, Kimberly-Clark employs a multi-channel approach, selling its products directly to various retail outlets, including supermarkets, drugstores, and warehouse clubs, as well as through e-commerce platforms. This strategy enables the company to reach a wide audience, ensuring that its products are accessible to consumers across different demographics and geographical locations. For its away-from-home products, the company sells directly to distributors and end-users, such as lodging facilities, office buildings, and public institutions, further expanding its market reach. Founded in 1872, Kimberly-Clark Corporation is headquartered in Dallas, Texas, and is listed on the New York Stock Exchange (NYSE) under the ticker symbol KMB, with its common stock classified under the GICS Sub Industry of Household Products.
Additional Sources for KMB Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
KMB Stock Overview
Market Cap in USD | 43,837m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Household Products |
IPO / Inception | 1984-12-17 |
KMB Stock Ratings
Growth 5y | 29.7% |
Fundamental | 58.9% |
Dividend | 50.8% |
Rel. Strength Industry | -10.1 |
Analysts | 3.4/5 |
Fair Price Momentum | 122.36 USD |
Fair Price DCF | 225.21 USD |
KMB Dividends
Dividend Yield 12m | 2.79% |
Yield on Cost 5y | 3.17% |
Annual Growth 5y | 2.76% |
Payout Consistency | 69.8% |
KMB Growth Ratios
Growth Correlation 3m | -68.8% |
Growth Correlation 12m | 74% |
Growth Correlation 5y | 39.7% |
CAGR 5y | 2.63% |
CAGR/Mean DD 5y | 0.27 |
Sharpe Ratio 12m | 0.53 |
Alpha | -2.27 |
Beta | 0.51 |
Volatility | 15.66% |
Current Volume | 5579.5k |
Average Volume 20d | 2593.2k |
As of December 21, 2024, the stock is trading at USD 131.32 with a total of 5,579,481 shares traded.
Over the past week, the price has changed by -0.02%, over one month by -2.85%, over three months by -5.87% and over the past year by +14.58%.
Partly, yes. Based on ValueRay Fundamental Analyses, Kimberly-Clark (NYSE:KMB) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 58.90 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KMB as of December 2024 is 122.36. This means that KMB is currently overvalued and has a potential downside of -6.82%.
Kimberly-Clark has received a consensus analysts rating of 3.40. Therefor, it is recommend to hold KMB.
- Strong Buy: 4
- Buy: 3
- Hold: 11
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, KMB Kimberly-Clark will be worth about 132.9 in December 2025. The stock is currently trading at 131.32. This means that the stock has a potential upside of +1.21%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 149.8 | 14.1% |
Analysts Target Price | 130.7 | -0.5% |
ValueRay Target Price | 132.9 | 1.2% |